These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 29212120)
1. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice. Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120 [TBL] [Abstract][Full Text] [Related]
2. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia. Varghese LN; Zhang JG; Young SN; Willson TA; Alexander WS; Nicola NA; Babon JJ; Murphy JM Growth Factors; 2014 Feb; 32(1):18-26. PubMed ID: 24438083 [TBL] [Abstract][Full Text] [Related]
4. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling. Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte-specific reporter line in zebrafish. Lin Q; Zhang Y; Zhou R; Zheng Y; Zhao L; Huang M; Zhang X; Leung AYH; Zhang W; Zhang Y Leukemia; 2017 May; 31(5):1206-1216. PubMed ID: 27811851 [TBL] [Abstract][Full Text] [Related]
6. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis. Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624 [TBL] [Abstract][Full Text] [Related]
7. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels. Geddis AE; Fox NE; Kaushansky K Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394 [TBL] [Abstract][Full Text] [Related]
9. Normal platelets and megakaryocytes are produced in vivo in the absence of thrombopoietin. Bunting S; Widmer R; Lipari T; Rangell L; Steinmetz H; Carver-Moore K; Moore MW; Keller GA; de Sauvage FJ Blood; 1997 Nov; 90(9):3423-9. PubMed ID: 9345025 [TBL] [Abstract][Full Text] [Related]
10. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl]. Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548 [TBL] [Abstract][Full Text] [Related]
11. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Ballmaier M; Germeshausen M; Schulze H; Cherkaoui K; Lang S; Gaudig A; Krukemeier S; Eilers M; Strauss G; Welte K Blood; 2001 Jan; 97(1):139-46. PubMed ID: 11133753 [TBL] [Abstract][Full Text] [Related]
12. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes. Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793 [TBL] [Abstract][Full Text] [Related]
13. Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia. Tijssen MR; di Summa F; van den Oudenrijn S; Zwaginga JJ; van der Schoot CE; Voermans C; de Haas M Br J Haematol; 2008 Jun; 141(6):808-13. PubMed ID: 18422784 [TBL] [Abstract][Full Text] [Related]
14. Developmental differences between newborn and adult mice in response to romiplostim. Sparger KA; Ramsey H; Lorenz V; Liu ZJ; Feldman HA; Li N; Laforest T; Sola-Visner MC Platelets; 2018 Jun; 29(4):365-372. PubMed ID: 28548028 [TBL] [Abstract][Full Text] [Related]
15. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations. Savoia A; Dufour C; Locatelli F; Noris P; Ambaglio C; Rosti V; Zecca M; Ferrari S; di Bari F; Corcione A; Di Stazio M; Seri M; Balduini CL Haematologica; 2007 Sep; 92(9):1186-93. PubMed ID: 17666371 [TBL] [Abstract][Full Text] [Related]
16. Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside. Deutsch VR; Tomer A Br J Haematol; 2013 Jun; 161(6):778-93. PubMed ID: 23594368 [TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin and the c-Mpl receptor: insights from gene targeting. Alexander WS Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337 [TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte development and platelet production. Deutsch VR; Tomer A Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888 [TBL] [Abstract][Full Text] [Related]
19. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro. Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567 [TBL] [Abstract][Full Text] [Related]
20. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]